PET Imaging CCR2 in Lung Inflammation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PET Imaging CCR2 in Lung Inflammation — Stella

Home/Lung Inflammation/

View on ClinicalTrials.gov

Recruiting

Back to Lung Inflammation trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Washington University School of Medicine, St Louis, Missouri

Key details

Phase

Very early testing

Sponsor

Washington University School of Medicine

Collaborators

National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~110 participants

Started

February 2018

Primary completion

December 2026

Age range

21 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.